Drug inhaler devices for pulmonary and nasal delivery of dry powder formulations. Research tool for absorption/bioavailibility of oral dosage forms. Contract development and testing. More
a UK-based drug delivery company (with a full listing on the London Stock Exchange) specialising in the development of delivery systems primarily for the pulmonary administration of pharmaceuticals More
Respirics, Inc. was founded in 2001 to provide innovative pulmonary drug delivery systems, including the formulation and development of novel and existing drugs for administration to the lung. More
All rights reserved. Terms and Conditions | Contact us
